Samsung Biologics's chart data is dated 2026-10-08. There is no active technical signal. There are 0 published signal records.
Samsung Biologics last closed at ₩1,222,000 (-4.31%) on 2026-10-08. Listed on KOSPI. Trailing 12 months PER is 28.4×. Its overall grade ranks 130 of 308 stocks in Healthcare.
About this company
Samsung Biologics last closed at ₩1,222,000 (-4.31%) on 2026-10-08. Listed on KOSPI.
Details →Reported results
Position in sector
Healthcare · Overall B · 130/308
Valuation grade F
Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- 바이오젠Customer
과거 공동 개발·위탁생산 관련 협력 이력
- 로슈Customer
글로벌 대형 제약사로 항체의약품 CMO/CDMO 고객 가능성
- 노바티스Customer
글로벌 제약사로 바이오의약품 위탁생산 수요가 큰 주요 고객
ETFs holding this stock
TIGER 바이오TOP10 · KIWOOM 의료AI · TIGER 200 헬스케어
Details →About Samsung Biologics
- What technical signals does Samsung Biologics (207940) have?
- Samsung Biologics current technical signals: no active technical signal.
- Is Samsung Biologics a cup-and-handle pattern?
- No. Samsung Biologics has no valid Cup signal right now.
- What published figures are available for Samsung Biologics?
- Market cap: KRW 57T. Trailing 12 months PER: 28.4×. Latest quarter PBR: 6.74×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Disclosed suppliers
2026-05-15 dataset
Turn what you saw on this name into a strategy
Ask Q about Samsung Biologics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.